temozolomide has been researched along with Astrocytosis in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Temozolomide is a conventional chemotherapy drug for adjuvant treatment of patients with high-risk gliomas, including grade II to grade IV." | 1.56 | Blockade of Cell Volume Regulatory Protein NKCC1 Increases TMZ-Induced Glioma Apoptosis and Reduces Astrogliosis. ( Amankulor, NM; Begum, G; Castro, MG; Ding, D; Dodelson, J; Fiesler, VM; Gayden, J; Guan, X; Hasan, MN; Hu, B; Jia, W; Kohanbash, G; Luo, L; Sun, B; Sun, D, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luo, L | 1 |
| Guan, X | 1 |
| Begum, G | 1 |
| Ding, D | 1 |
| Gayden, J | 1 |
| Hasan, MN | 1 |
| Fiesler, VM | 1 |
| Dodelson, J | 1 |
| Kohanbash, G | 1 |
| Hu, B | 1 |
| Amankulor, NM | 1 |
| Jia, W | 1 |
| Castro, MG | 1 |
| Sun, B | 1 |
| Sun, D | 1 |
1 other study available for temozolomide and Astrocytosis
| Article | Year |
|---|---|
Blockade of Cell Volume Regulatory Protein NKCC1 Increases TMZ-Induced Glioma Apoptosis and Reduces Astrogliosis.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Biomarkers, Tumor; Cell Movement; Cell Prolif | 2020 |